As of August 04, 2026, the three largest insider holders of QNCX are David Lamond (Director, 4.65Mn shares), Stephen S. Dominy (Chief Scientific Officer, 1.22Mn shares), Dirk Thye (Ceo And Cmo, 994.88K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Christopher P. Lowe | Interim Ceo, Coo Cfo | 265,000 | 0 | 04 Mar, 2022 |
| Philip S Low | - | 455,309 | 63,974 | 23 May, 2022 |
| Ted Monohon | Chief Accounting Officer Vp | 27,440 | 0 | 06 Mar, 2023 |
| Luca Benatti | - | 39,179 | 0 | 29 Dec, 2025 |
| Charles S. Ryan | President | 130,009 | 0 | 20 Jun, 2025 |
| Dirk Thye | Ceo And Cmo | 255,000 | 739,885 | 11 Dec, 2025 |
| Karen L. Smith | Chief Medical Officer | 194,690 | 0 | 27 May, 2022 |
| Casey Lynch | Chief Executive Officer | 109,895 | 0 | 19 Nov, 2021 |
| Michael J. Detke | Chief Medical Officer | 140,000 | 0 | 04 Mar, 2022 |
| David Lamond | - | 2,302,291 | 2,347,545 | 14 Dec, 2023 |
| Leslie Holsinger | Evp, Preclinical Development | 148,080 | 0 | 08 Jun, 2022 |
| Margaret Mcloughlin | - | 8,000 | 0 | 09 Aug, 2023 |
| Stephen S. Dominy | Chief Scientific Officer | 0 | 1,217,086 | 12 Nov, 2021 |
| Brendan Hannah | Cbo, Coo Cco | 361,827 | 0 | 06 Dec, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 23 Jan, 2026 | Charles S. Ryan | Employee Stock Option (Right to Buy) | A | 200,000 | $0.00 | 200,000 | D | A |
| 23 Jan, 2026 | Dirk Thye | Employee Stock Option (Right to Buy) | A | 1,000,000 | $0.00 | 1,000,000 | D | A |
| 23 Jan, 2026 | Charles S. Ryan | Employee Stock Option (Right to Buy) | A | 200,000 | $0.00 | 200,000 | D | A |
| 23 Jan, 2026 | Dirk Thye | Employee Stock Option (Right to Buy) | A | 1,000,000 | $0.00 | 1,000,000 | D | A |
| 23 Jan, 2026 | Brendan Hannah | Employee Stock Option (Right to Buy) | D | 365,000 | $0.00 | 365,000 | D | A |
| 23 Jan, 2026 | Charles S. Ryan | Employee Stock Option (Right to Buy) | A | 200,000 | $0.00 | 200,000 | D | A |
| 23 Jan, 2026 | Dirk Thye | Employee Stock Option (Right to Buy) | A | 1,000,000 | $0.00 | 1,000,000 | D | A |
| 02 Jan, 2026 | Christopher J. Senner | Director Stock Option (Right to Buy) | A | 21,810 | $0.00 | 21,810 | D | A |
| 02 Jan, 2026 | June Bray | Director Stock Option (Right to Buy) | A | 18,724 | $0.00 | 18,724 | D | A |
| 02 Jan, 2026 | Margaret Mcloughlin | Director Stock Option (Right to Buy) | A | 19,547 | $0.00 | 19,547 | D | A |
| 02 Jan, 2026 | Christopher J. Senner | Director Stock Option (Right to Buy) | A | 21,810 | $0.00 | 21,810 | D | A |
| 02 Jan, 2026 | David Lamond | Director Stock Option (Right to Buy) | A | 29,423 | $0.00 | 29,423 | D | A |
| 02 Jan, 2026 | Christopher J. Senner | Director Stock Option (Right to Buy) | A | 21,810 | $0.00 | 21,810 | D | A |
| 26 Dec, 2025 | Luca Benatti | Common Stock | D | 50,000 | $3.47 | 39,179 | D | S |
| 10 Dec, 2025 | Dirk Thye | Common Shares | D | 739,885 | $0.00 | 255,000 | D | G |
| 10 Dec, 2025 | Dirk Thye | Common Shares | D | 739,885 | $0.00 | 255,000 | D | G |
| 10 Dec, 2025 | Dirk Thye | Common Shares | D | 739,885 | $0.00 | 255,000 | D | G |
| 10 Dec, 2025 | Dirk Thye | Common Shares | A | 739,885 | $0.00 | 739,885 | I | G |
| 10 Dec, 2025 | Dirk Thye | Common Shares | A | 739,885 | $0.00 | 739,885 | I | G |
| 10 Dec, 2025 | Dirk Thye | Common Shares | A | 739,885 | $0.00 | 739,885 | I | G |